144 related articles for article (PubMed ID: 21585376)
1. Development of effervescent tablets containing benzonidazole complexed with cyclodextrin.
Maximiano FP; Costa GH; de Sá Barreto LC; Bahia MT; Cunha-Filho MS
J Pharm Pharmacol; 2011 Jun; 63(6):786-93. PubMed ID: 21585376
[TBL] [Abstract][Full Text] [Related]
2. Modulated dissolution rate from the inclusion complex of antichagasic benznidazole and cyclodextrin using hydrophilic polymer.
Sá-Barreto LC; Gustmann PC; Garcia FS; Maximiano FP; Novack KM; Cunha-Filho MS
Pharm Dev Technol; 2013; 18(5):1035-41. PubMed ID: 22200091
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
4. Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers.
Soares-Sobrinho JL; Santos FL; Lyra MA; Alves LD; Rolim LA; Lima AA; Nunes LC; Soares MF; Rolim-Neto PJ; Torres-Labandeira JJ
Carbohydr Polym; 2012 Jun; 89(2):323-30. PubMed ID: 24750726
[TBL] [Abstract][Full Text] [Related]
5. Benznidazole microcrystal preparation by solvent change precipitation and in vivo evaluation in the treatment of Chagas disease.
Maximiano FP; de Paula LM; Figueiredo VP; de Andrade IM; Talvani A; Sá-Barreto LC; Bahia MT; Cunha-Filho MS
Eur J Pharm Biopharm; 2011 Aug; 78(3):377-84. PubMed ID: 21397015
[TBL] [Abstract][Full Text] [Related]
6. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
7. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
[TBL] [Abstract][Full Text] [Related]
8. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
9. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
García MC; Manzo RH; Jimenez-Kairuz AF
Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
Taneri F; Ozcan I; Guneri T
Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
[TBL] [Abstract][Full Text] [Related]
12. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
13. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
Labib GS
Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
[TBL] [Abstract][Full Text] [Related]
14. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
[TBL] [Abstract][Full Text] [Related]
15. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin.
Ozdemir N; Erkin J
Drug Dev Ind Pharm; 2012 Mar; 38(3):331-40. PubMed ID: 22059382
[TBL] [Abstract][Full Text] [Related]
17. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
Cetin EO; Ilem D; Gundogdu E; Asikoglu M; Kirilmaz L
Pharmazie; 2011 Sep; 66(9):672-6. PubMed ID: 22026122
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization.
Palem CR; Kumar Battu S; Gannu R; Yamsani VV; Repka MA; Yamsani MR
Pharm Dev Technol; 2012; 17(3):321-32. PubMed ID: 21265709
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
[TBL] [Abstract][Full Text] [Related]
20. Benznidazole in vitro dissolution release from a pH-sensitive drug delivery system using Zif-8 as a carrier.
de Moura Ferraz LR; Tabosa AÉGA; da Silva Nascimento DDS; Ferreira AS; Silva JYR; Junior SA; Rolim LA; Rolim-Neto PJ
J Mater Sci Mater Med; 2021 May; 32(6):59. PubMed ID: 33999312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
